MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 139 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $45,434,000 | -79.5% | 466,422 | -75.4% | 0.01% | -79.6% |
| Q1 2021 | $221,432,000 | +5.3% | 1,893,066 | +0.1% | 0.05% | -1.8% |
| Q4 2020 | $210,199,000 | -6.1% | 1,890,787 | +0.3% | 0.06% | -17.9% |
| Q3 2020 | $223,845,000 | +16.5% | 1,885,327 | +11.1% | 0.07% | +9.8% |
| Q2 2020 | $192,199,000 | +69.6% | 1,697,119 | 0.0% | 0.06% | +38.6% |
| Q1 2020 | $113,300,000 | -26.7% | 1,697,119 | 0.0% | 0.04% | -4.3% |
| Q4 2019 | $154,625,000 | +6.5% | 1,697,119 | +0.8% | 0.05% | -4.2% |
| Q3 2019 | $145,131,000 | -17.7% | 1,683,269 | +0.0% | 0.05% | -14.3% |
| Q2 2019 | $176,423,000 | -15.4% | 1,683,262 | +1.1% | 0.06% | -15.2% |
| Q1 2019 | $208,489,000 | +11.1% | 1,664,452 | 0.0% | 0.07% | +1.5% |
| Q4 2018 | $187,617,000 | -47.4% | 1,664,452 | 0.0% | 0.06% | -37.5% |
| Q3 2018 | $356,409,000 | -7.0% | 1,664,452 | +21.5% | 0.10% | -1.0% |
| Q2 2018 | $383,246,000 | +229.2% | 1,370,252 | +37.5% | 0.10% | +218.2% |
| Q1 2018 | $116,427,000 | – | 996,893 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 463,000 | $99,142,000 | 4.55% |
| Rock Springs Capital Management LP | 342,000 | $73,232,000 | 2.65% |
| ACUTA CAPITAL PARTNERS, LLC | 33,000 | $7,066,000 | 2.52% |
| HealthCor Management, L.P. | 262,860 | $56,286,000 | 1.87% |
| Baker Brothers Advisors | 1,169,278 | $250,377,000 | 1.65% |
| EMORY UNIVERSITY | 11,391 | $2,439,000 | 1.60% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 8,690 | $1,862,000 | 1.48% |
| GREAT POINT PARTNERS LLC | 40,400 | $8,651,000 | 1.35% |
| SHIKIAR ASSET MANAGEMENT INC | 15,341 | $3,285,000 | 1.28% |
| ARMISTICE CAPITAL, LLC | 80,000 | $17,130,000 | 1.03% |